Europe/Sponsors

Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a large network of distributors.
With more than 7,400 employees in the world, bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

• Its products are used for diagnosing infectious diseases (HIV, hepatitis, tuberculosis, etc.) and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies.
• They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

• Analyzing a biological sample to detect and measure the presence of disease-causing agents (bacteria, viruses,…) or substances produced by the body.
• Essential first step before any clinical diagnosis.
• Analyzing a food, drug or air sample to monitor and confirm the quality of the production process.
• Necessary to ensure safety in food as well as in pharmaceutical and cosmetic products.

The central idea of ERASynBio is to promote the robust development of Synthetic Biologyby structuring and coordinating national efforts and investment. ERASynBio's main activities include developing a strategic research agenda / white paper, which supports the emergence of national Synthetic Biology programmes and lays the ground for transnational funding activities via joint calls in the project. ERASynBio stimulates and tackles the interdisciplinary nature and immaturity of the field by offering training and educational possibilities, establishing an interdisciplinary advisory board and inviting observers of other funding organisations. Tight collaboration between academia and industry aiming to fertilize the innovation process is occuring on several levels. To adhere to ethical, legal and societal aspects as well as to technical issues like standardisation and infrastructure development ERASynBio is tracing the ongoing work and research on these framework conditions, integrating them in its strategic documents and activities.